APA (7th ed.) Citation

Norshidah, H., Leow, C. H., Ezleen, K. E., Wahab, H. A., Vignesh, R., Rasul, A., & Lai, N. S. (2023). Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach. Frontiers in cellular and infection microbiology, 13, 1061937. https://doi.org/10.3389/fcimb.2023.1061937

Chicago Style (17th ed.) Citation

Norshidah, Harun, Chiuan Herng Leow, Kamarulzaman Ezatul Ezleen, Habibah A. Wahab, Ramachandran Vignesh, Azhar Rasul, and Ngit Shin Lai. "Assessing the Potential of NS2B/NS3 Protease Inhibitors Biomarker in Curbing Dengue Virus Infections: In Silico Vs. In Vitro Approach." Frontiers in Cellular and Infection Microbiology 13 (2023): 1061937. https://doi.org/10.3389/fcimb.2023.1061937.

MLA (9th ed.) Citation

Norshidah, Harun, et al. "Assessing the Potential of NS2B/NS3 Protease Inhibitors Biomarker in Curbing Dengue Virus Infections: In Silico Vs. In Vitro Approach." Frontiers in Cellular and Infection Microbiology, vol. 13, 2023, p. 1061937, https://doi.org/10.3389/fcimb.2023.1061937.